NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma

Glioblastoma (GBM) is the most common primary intracranial malignancy. GBM still exhibits high recurrence and mortality rates even following combined treatment with surgery, radiotherapy and chemotherapy, Therefore, the identification of novel therapeutic targets is urgent. Previous research has sho...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Rep
Hlavní autoři: Guo, Qiuyun, Han, Na, Shi, Lei, Yang, Li, Zhang, Xiaoxi, Zhou, Yangmei, Yu, Shiying, Zhang, Mengxian
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2019
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667917/
https://ncbi.nlm.nih.gov/pubmed/31322259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7227
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky